Personalizing therapy in early gestational diabetes.

Area of Science:

• Obstetrics and Gynecology
• Endocrinology
• Perinatal Medicine

Background:

• Early gestational diabetes mellitus (eGDM) detection is rising due to increased obesity and early screening.
• Diagnostic criteria and management strategies for eGDM lack definitive consensus.
• Evidence on maternal and fetal outcomes and early treatment impact requires clarification.

Purpose of the Study:

• To review current evidence on eGDM diagnostic thresholds.
• To summarize maternal and fetal outcomes associated with eGDM.
• To evaluate the benefits and risks of early eGDM treatment.

Main Methods:

• Review of observational studies and the Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) randomized controlled trial (RCT).
• Analysis of intervention effects on neonatal respiratory distress and small-for-gestational-age infants.
• Exploration of alternative diagnostic approaches using composite risk scores.

Main Results:

• Observational studies link eGDM to adverse outcomes, but intervention evidence is limited.
• The TOBOGM trial showed early intervention reduced neonatal respiratory distress but increased small-for-gestational-age risk in certain glycemic bands.
• A significant proportion of untreated eGDM cases reverted to normoglycemia spontaneously.

Conclusions:

• Current diagnostic criteria may not effectively identify eGDM pregnancies benefiting from intervention.
• Redefining diagnostic thresholds and incorporating clinical risk factors could improve intervention identification.
• Further well-designed RCTs are crucial for establishing accurate eGDM identification and optimal treatment strategies.